BioMILD at Nearly 10 Years: Risk-Adapted LDCT Screening Sustains Early Lung Cancer Detection With Extended Intervals
BioMILD at Nearly 10 Years: Risk-Adapted LDCT Screening Sustains Early Lung Cancer Detection With Extended Intervals Oncodaily
BioMILD at Nearly 10 Years: Risk-Adapted LDCT Screening Sustains Early Lung Cancer Detection With Extended Intervals Oncodaily
Karmanos Cancer Institute Names New Associate Center Director for the Cancer Network DBusiness Magazine
Exploring Early Breast Cancer: Advancing Research Across the Treatment Journey Daiichi Sankyo US
Approximately a third of patients with breast cancer reported increased fatigue 2 years after receiving chemotherapy, but addressing any depression and/or stress may significantly reduce this lethargy. This cohort study including nearly 400 women also showed common evaluations clinicians perform when diagnosing…
AVBCC Recognizes Iovance Biotherapeutics’ Dr. Fred Vogt with Inaugural Global Cancer Research & Innovation Award The Des Moines Register
NIH Honors Sylvester Scientist Developing Cancer Therapy That Can Evolve to Outsmart Tumors South Florida Hospital News
Ростех впервые показал инновационный кольпоскоп для ранней диагностики рака Первый Технический
Ростех впервые показал инновационный кольпоскоп для ранней диагностики рака Первый Технический
В России зарегистрирован таргетный препарат «Элефуза®» для терапии рака яичников и рака молочной железы ФАРМПРОМ
AVBP Stock Crashes More Than 48% To All-Time Low After Lung Cancer Trial Setback – Retail Calls It ‘Way Undervalued’ TradingView
Власти развеяли миф о 12-кратном снижении расходов на лечение рака ВТамбове
UCLA Oncologist Dennis Slamon Wins Award for Cancer Treatments MyNewsLA.com
What Does ERASur’s Global Expansion Mean for Colorectal Cancer Care? - Alliance for Clinical Trials in Oncology Oncodaily
New Phase III Trial Uses MRD Testing to Personalize Treatment for Early-Stage Breast Cancer - Alliance for Clinical Trials in Oncology Oncodaily